Philips & Apollo Hospitals Sign MoU to Advance Stroke & Structural Heart Disease Care in India

The collaboration will focus on strengthening technology-enabled care pathways informed by real-world clinical practice.

Philips and Apollo Hospitals have signed a non-exclusive Memorandum of Understanding (MoU) to explore initiatives aimed at advancing stroke care and structural heart disease management in India. Any proposed initiatives under the agreement will be subject to definitive agreements and regulatory approvals.

The collaboration will focus on strengthening technology-enabled care pathways informed by real-world clinical practice. The companies intend to combine Philips’ advanced imaging and image-guided therapy platforms with Apollo’s clinical expertise to support integrated decision-making across diagnosis and intervention, particularly in complex and time-sensitive cases.

The agreement comes amid a rising burden of cardiovascular and neurological diseases in India. According to The Lancet Neurology, India recorded more than 1.25 million new stroke cases in 2021, nearly double the number reported in 1990. Cardiovascular diseases remain the leading cause of death in the country, accounting for nearly one-third of all deaths, as per data from the Registrar General of India.

Roy Jakobs, Chief Executive Officer of Philips, said healthcare systems in India are facing increasing pressure from the rising incidence of complex cardiovascular and neurological conditions. “Through this collaboration with Apollo Hospitals, Philips aims to bring its global platforms in advanced imaging and image-guided therapies to help shape more resilient, data-driven care pathways supporting earlier intervention and greater precision,” he said.

Dr. Prathap C. Reddy, Founder and Chairman of Apollo Hospitals Group, said integrating advanced technology with clinical expertise is essential to deliver scalable care. He noted that the collaboration would focus on strengthening stroke and structural heart disease pathways through precision imaging and faster interventions.

The MoU outlines two priority areas. In structural heart disease, the parties intend to enhance procedural accuracy, optimize contrast usage, and improve real-time imaging guidance. In stroke care, the focus will be on accelerating imaging workflows, reducing door-to-needle time, and streamlining patient pathways to enable intervention within the critical “golden hour.”

The MoU was signed by Roy Jakobs and Shobana Kamineni, Executive Vice Chairperson of Apollo Health Co Ltd., in the presence of Dr. Reddy.

Stay tuned for more such updates on Digital Health News